Circulating Vimentin Over-Expression in Patients with Oral Sub Mucosal Fibrosis and Oral Squamous Cell Carcinoma

被引:0
作者
Sadhna Aggarwal
Baldeep Singh
Suresh C. Sharma
Satya N. Das
机构
[1] All India Institute of Medical Sciences,Department of Biotechnology and Otorhinolaryngology
[2] Emeritus Scientist,undefined
[3] Indian Council of Medical Research,undefined
来源
Indian Journal of Otolaryngology and Head & Neck Surgery | 2022年 / 74卷
关键词
Vimentin; ELISA; Biomarker; OSMF; OSCC;
D O I
暂无
中图分类号
学科分类号
摘要
Oral squamous cell carcinoma (OSCC) is one of the most common (90%) types of oral carcinomas in the world. It is the 2nd most common and 3rd deadliest cancer in India. The lack of early detection marker is one of the major causes of worst prognosis. The vimentin belongs to intermediate filament family proteins which plays significant role in maintaining cellular integrity. Over-expression of vimentin has been widely reported in many epithelial cancers however the information regarding its prevalence in the oral cancers still needs further scientific intervention. The expression level of circulating vimentin protein in serum samples (n = 30) of oral submucous fibrosis (OSMF), OSCC patients and healthy controls were measured by performing ELISA. The serum level of vimentin was significantly higher in OSMF (p < 0.01) and OSCC (p < 0.003) patients as compared to healthy subjects. The circulating vimentin levels showed a gradual increase with increasing disease status (normal < OSMF < OSCC). Circulatory levels of vimentin may ba useful indicator of disease progression and as a suitable target for therapeutic intervention of oral submucous fibrosis and oral carcinoma.
引用
收藏
页码:510 / 515
页数:5
相关论文
共 100 条
[1]  
Jerjes W(2012)The effect of tobacco and alcohol and their reduction/cessation on mortality in oral cancer patients: Short communication Head Neck Oncol 4 6-549
[2]  
Upile T(1996)Alcoholism: Independent predictor of survival in patients with head and neck cancer J Natl Cancer Inst 88 542-11S
[3]  
Radhi H(2001)Demographics and occurrence of oral and pharyngeal cancers: The outcomes, the trends, the challenge J Am Dent Assoc 132 7S-793
[4]  
Deleyiannis FWB(1983)Intensive combination chemotherapy for cancer of the oral cavity Cancer 52 790-40
[5]  
Thomas DB(2014)Expression of vascular endothelial growth factor (VEGF) in patients with oral squamous cell carcinoma and its clinical significance Clin Chim Acta 436 35-21
[6]  
Vaughan TL(2015)Galectin-1 and galectin-3: Plausible tumour markers for oral squamous cell carcinoma and suitable targets for screening high-risk population Clin Chim Acta 442 13-265
[7]  
Davis S(2014)Oral submucous fibrosis and its dermatological relation Indian Dermatol Online J 5 260-438
[8]  
Silverman S(2017)Identification of a combined biomarker for malignant transformation in oral submucous fibrosis J Oral Pathol Med 46 431-6948
[9]  
Khanna NN(2017)The role of vimentin in regulating cell invasive migration in dense cultures of breast carcinoma cells Nano Lett 17 6941-3046
[10]  
Srivastava PK(2011)Vimentin in cancer and its potential as a molecular target for cancer therapy Cell Mol Life Sci 68 3033-2062